Classification of preeclampsia according to molecular clusters with the goal of achieving personalized prevention

The prevention of pre-eclampsia is difficult due to the syndromic nature and multiple underlying mechanisms of this severe complication of pregnancy. The current clinical distinction between early- and late-onset disease, although clinically useful, does not reflect the true nature and complexity of...

Teljes leírás

Bibliográfiai részletek
Szerzők: Than Nándor Gábor
Romero Roberto
Posta Máté
Györffy Dániel
Szalai Gábor
Rossi Simona W
Szilágyi András
Hupuczi Petronella
Nagy Sándor
Török Olga
Tarca Adi L
Erez Offer
Ács Nándor
Papp Zoltán
Dokumentumtípus: Cikk
Megjelent: 2024
Sorozat:JOURNAL OF REPRODUCTIVE IMMUNOLOGY 161
Tárgyszavak:
doi:10.1016/j.jri.2023.104172

mtmt:34477407
Online Access:https://publikacio.ppke.hu/3576

MARC

LEADER 00000nab a2200000 i 4500
001 publ3576
005 20260326105847.0
008 260326s2024 hu o 000 Angol d
022 |a 0165-0378 
024 |a 10.1016/j.jri.2023.104172  |2 doi 
024 |a 34477407  |2 mtmt 
040 |a PPKE Publikáció Repozitórium  |b hun 
041 |a Angol 
100 1 |a  Than Nándor Gábor 
245 1 0 |a Classification of preeclampsia according to molecular clusters with the goal of achieving personalized prevention  |c  Than Nándor Gábor  |h [elektronikus dokumentum] 
260 |c 2024 
490 0 |a JOURNAL OF REPRODUCTIVE IMMUNOLOGY  |v 161 
520 3 |a The prevention of pre-eclampsia is difficult due to the syndromic nature and multiple underlying mechanisms of this severe complication of pregnancy. The current clinical distinction between early- and late-onset disease, although clinically useful, does not reflect the true nature and complexity of the pathologic processes leading to pre-eclampsia. The current gaps in knowledge on the heterogeneous molecular pathways of this syndrome and the lack of adequate, specific diagnostic methods are major obstacles to early screening and tailored preventive strategies. The development of novel diagnostic tools for detecting the activation of the identified disease pathways would enable early, accurate screening and personalized preventive therapies. We implemented a holistic approach that includes the utilization of different proteomic profiling methods of maternal plasma samples collected from various ethnic populations and the application of systems biology analysis to plasma proteomic, maternal demographic, clinical characteristic, and placental histopathologic data. This approach enabled the identification of four molecular subclasses of pre-eclampsia in which distinct and shared disease mechanisms are activated. The current review summarizes the results and conclusions from these studies and the research and clinical implications of our findings. 
650 4 |a Immunológia 
650 4 |a Szülészet és nőgyógyászat 
700 1 |a  Romero Roberto  |e aut 
700 1 |a  Posta Máté  |e aut 
700 1 |a  Györffy Dániel  |e aut 
700 1 |a  Szalai Gábor  |e aut 
700 1 |a  Rossi Simona W  |e aut 
700 1 |a  Szilágyi András  |e aut 
700 1 |a  Hupuczi Petronella  |e aut 
700 1 |a  Nagy Sándor  |e aut 
700 1 |a  Török Olga  |e aut 
700 1 |a  Tarca Adi L  |e aut 
700 1 |a  Erez Offer  |e aut 
700 1 |a  Ács Nándor  |e aut 
700 1 |a  Papp Zoltán  |e aut 
856 4 0 |u https://publikacio.ppke.hu/id/eprint/3576/1/1-s2.0-S0165037823003789-main.pdf  |z Dokumentum-elérés